Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.
Ann Oncol
; 28(11): 2813-2819, 2017 Nov 01.
Article
in En
| MEDLINE
| ID: mdl-29045520
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridines
/
Thyroid Neoplasms
/
Diagnostic Imaging
/
Carcinoma, Medullary
/
Anilides
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2017
Type:
Article